Regenerative Medicine Market (By Product: Gene Therapies, Cell Therapies, Tissue-Engineering, Progenitor and Stem Cell Therapies, and Others; By Application: Wound Care, Musculoskeletal, Ophthalmology, Oncology, Cardiovascular, and Others) - Global Industry Analysis, Market Size, Share, Growth, Trends, Regional Outlook and Forecasts 2021 - 2030

The regenerative medicine market size was valued at USD 9.81 billion in 2021 and is predicted to be worth around USD 37.92 billion by 2030 with a CAGR of 16.2% from 2021 to 2030.

Regenerative Medicine Market Size 2020 to 2030

Key market Insights:

Stem cell therapy is one of the most revolutionary applications of regenerative medicine in the real-world scenario.  Stem cell therapy encourages the repair response of ailing, dysfunctional or wounded tissue by means of stem cells or their by products. It is the next big thing in organ transplantation and makes use of cells in the place of donor organs, that are limited in stock. Scientists cultivate stem cells in a laboratory. These stem cells are operated to specialize into particular cells, such as blood cells, heart muscle or nerve cells. The specific cells can then be implanted into an individual. Stem cells have the capability to build all tissue in the human body, therefore have great possibility for future healing uses in tissue repair and regeneration.

Crucial factors accountable for market growth are:

  • Increasing prevalence of chronic ailments
  • Growing incidence of genetic disorders
  • Rapidly increasing trauma cases
  • Growing investment in research and development for regenerative medicine
  • Strong product pipeline of regenerative medicine products
  • Increasing popularity of stem cell therapy

Report Scope of the Regenerative Medicine Market

Report Highlights Details
Market Size USD 37.92 Billion by 2030
Growth Rate CAGR of 16.2% from 2021 to 2030
Largest Market North America
Fastest Growing Market Asia Pacific
Base Year 2021
Forecast Period 2021 to 2030
Segments Covered Product, Application, Region
Companies Mentioned Integra LifeSciences Corporation, Aspect Biosystems, Amgen, Inc., Medtronic plc, AstraZeneca, Novartis AG, Smith & Nephew plc, MiMedx Group, Shenzhen SibionoGeneTech Co., Ltd., and Baxter


Significant Market Trends:

Tissue-Engineering Segment Reported Foremost Market Stake in 2019

Tissue-Engineering segment recorded the prime market share in the global regenerative medicine Market in 2019. The key reason for the hefty share of the tissue-engineering segment is multiple advantages such as ability to replace a defective structure with an entirely living structure and potential in developing treatments for previously untreatable medical conditions. Moreover, high investment in research and development for developing effective treatments, and constant launch of new and effective products are expected to boost the demand in tissue engineering segment.

The stem cell therapies segment is projected grow at the highest CAGR during the forecast period mainly due to increasing popularity of stem cell related treatment options and high investment by major manufacturers. Other factors responsible for high growth of stem cells therapy segment are increasing geriatric population, and increasing trauma cases worldwide.

Musculoskeletal Applications are Projected to Dominate the Regenerative Medicine Market Revenue

Regenerative medicine, specifically cellular therapy, is a rapidly emerging field that is being explored as a possibility for the repair of function in numerous disease areas including musculoskeletal ailments. High research and development activity in use of regenerative medicine for the treatment of musculoskeletal disorders is the major reason for the high revenue share of regenerative medicines.

Oncology segment will hold a significant share in the global regenerative medicine market mainly due to the high incidence of cancer globally and increasing demand for development of new technologies for the treatment of cancer.

North America is Estimated to be the Largest Market for Regenerative Medicine

The research report covers key trends and prospects of regenerative medicine products across different geographical regions including North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Geographically, regenerative medicine market is conquered by North America owing to high incidence of chronic diseases and presence of sophisticated healthcare framework. On the other hand, Asia-Pacific is anticipated to witness the rapid growth rate, on account of increasing healthcare expenditure and growing investment by major manufactures to launch new products.

Global Regenerative Medicine Market 2020-2027

Top Players contending in the Market:

The companies focusing on research and development are expected to lead the global regenerative medicine market. Leading competitors contending in global regenerative medicine market are as follows:

  • Integra LifeSciences Corporation
  • Aspect Biosystems
  • Amgen, Inc.
  • Medtronic plc
  • AstraZeneca
  • Novartis AG
  • Smith & Nephew plc
  • MiMedx Group
  • Shenzhen SibionoGeneTech Co., Ltd.
  • Baxter

In order to better recognize the current status of regenerative medicine, and policies adopted by the foremost countries, Precedence Research predicted the future evolution of the regenerative medicine market. This research study bids qualitative and quantitative insights on regenerative medicine market and assessment of market size and growth trend for potential market segments.

Major Market Segments Covered:

By Product

  • Gene Therapies
  • Cell Therapies
  • Tissue-Engineering
  • Progenitor and Stem Cell Therapies
  • Others

By Application

  • Wound Care
  • Musculoskeletal
  • Ophthalmology
  • Oncology
  • Cardiovascular
  • Others

By Geography

  • North America
    • S.
    • Canada
  • Europe
    • Germany
    • France
    • United Kingdom
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC
    • North Africa
    • South Africa
    • Rest of Middle East & Africa

Frequently Asked Questions

What is the current size of the global regenerative medicine market?
According to Precedence Research, the regenerative medicine market size was valued at USD 9.81 billion in 2021 and is predicted to surpass around USD 37.92 billion by 2030.
The global regenerative medicine market is expected to grow at a CAGR of 16.2% during the forecast period 2021 to 2030.
Factors such as increasing prevalence of chronic disorders and genetic disorders, increasing popularity of stem cells, increasing number of trauma emergencies is driving the growth of regenerative medicine market. The role of regenerative medicine in post trauma recovery is constantly evolving as more and more research is showing positive results. The use of regenerative medicine can be a landmark moment in the history of healthcare that will transform the treatment of chronic ailments and trauma related conditions. Thus, the high incidence of chronic ailments is driving the growth of regenerative medicine market.
Regenerative medicine is the division of medicine that promote methods to repair, regrow or replace injured or diseased tissues, organs or cells. Regenerative medicine comprises of the formation and use of remedial stem cells, manufacturing of artificial organs, and tissue engineering. The combinations of tissue engineering, cell and gene therapies can strengthen the natural healing procedure in the places it is desired most, or occupy the role of a permanently injured organ. Regenerative medicine is a rather new field that connects experts in chemistry, biology, engineering, computer science, robotics, medicine, genetics and other domains to find explanations to some of the most interesting medical problems confronted by humankind.
In 2019, North America dominated the global market with a market share of more than 45%.
The major companies operating in the worldwide regenerative medicine are Integra LifeSciences Corporation, Aspect Biosystems, Amgen, Inc., Medtronic plc, AstraZeneca, Novartis AG, Smith & Nephew plc, MiMedx Group, Shenzhen SibionoGeneTech Co., Ltd., and Baxter among others.
Tissue-Engineering segment recorded the prime market share in the global regenerative medicine Market in 2019.


   USD 4500
   USD 7000
   USD 9000


No cookie-cutter, only authentic analysis – take the 1st step to become an Precedence Research client

Get a Sample